Andrew Baird researcher
Baird, Andrew, 1954-
Baird, Andrew
Baird, Andrew, 1954 July 27-
VIAF ID: 36016014 (Personal)
Permalink: http://viaf.org/viaf/36016014
Preferred Forms
-
100 0 _
‡a
Andrew Baird
‡c
researcher
-
200 _ 1 ‡a Baird ‡b Andrew ‡f 1954-
-
100 1 _
‡a
Baird, Andrew
-
100 1 _
‡a
Baird, Andrew
-
100 1 _ ‡a Baird, Andrew
-
100 1 0
‡a
Baird, Andrew,
‡d
1954 July 27-
-
100 1 _ ‡a Baird, Andrew, ‡d 1954-
-
100 1 _ ‡a Baird, Andrew, ‡d 1954-
-
100 1 _ ‡a Baird, Andrew, ‡d 1954-
4xx's: Alternate Name Forms (3)
Works
| Title | Sources |
|---|---|
| The Fibroblast growth factor family |
|
| In vitro and in vivo evidence that the C-terminus of preproenkephalin-A circulates as an 8500-dalton molecule |
|
| In vivo measurement of glioma-induced vascular permeability |
|
| Intravenous phage display identifies peptide sequences that target the burn-injured intestine |
|
| Isolation and characterization of a γ1-melanotropin-like peptide from bovine neurointermediate pituitary |
|
| Isolation of ACTH1-39,ACTH1-38 and CLIP from the calf anterior pituitary |
|
| Juvenile Nasopharyngeal Angiofibroma Contain an Angiogenic Growth Factor: Basic FGF |
|
| Local fate and distribution of locally infused basic FGF. The example of the rat brain and the Xenopus tail mesenchyme. |
|
| Localization of bFGF in human transplant coronary atherosclerosis |
|
| Lost your nerve? Modulating the parasympathetic nervous system to treat inflammatory bowel disease |
|
| Matrix-mediated gene transfer to brain cortex and dorsal root ganglion neurones by retrograde axonal transport after dorsal column lesion |
|
| Molecular forms of the putative enkephalin precursor BAM-12P in bovine adrenal, pituitary, and hypothalamus |
|
| The molecular weight forms of rat growth hormone secreted in response to growth hormone-releasing factor |
|
| Monitoring Neutrophil-Expressed Cell Surface Esophageal Cancer Related Gene-4 after Severe Burn Injury |
|
| Multiple forms of bFGF: differential nuclear and cell surface localization |
|
| Neurotrophic factor synergy is required for neuronal survival and disinhibited axon regeneration after CNS injury |
|
| Non-invasive detection of spatio-temporal activation of SBE and NFAT5 promoters in transgenic reporter mice following stroke |
|
| Non-invasive quantification of brain tumor-induced astrogliosis |
|
| The noninvasive, quantitative, in vivo assessment of adenoviral-mediated gene delivery in skin wound biomaterials |
|
| Open reading frame mining identifies a TLR4 binding domain in the primary sequence of ECRG4 |
|
| Ovine corticotropin-releasing factor stimulates the concomitant secretion of corticotropin, beta-lipotropin, beta-endorphin and gamma-melanotropin by the bovine adenohypophysis in vitro |
|
| Pentoxifylline modulates intestinal tight junction signaling after burn injury: effects on myosin light chain kinase |
|
| Phagocytosis and deposition of vascular beta-amyloid in rat brains injected with Alzheimer beta-amyloid |
|
| Phosphodiesterase inhibition attenuates alterations to the tight junction proteins occludin and ZO-1 in immunostimulated Caco-2 intestinal monolayers. |
|
| Physiological studies with somatocrinin, a growth hormone-releasing factor |
|
| Postinjury vagal nerve stimulation protects against intestinal epithelial barrier breakdown |
|
| Preclinical Models of Wound Healing: Is Man the Model? Proceedings of the Wound Healing Society Symposium |
|
| The proteome of mouse brain microvessel membranes and basal lamina |
|
| Pulmonary preconditioning, injury, and inflammation modulate expression of the candidate tumor suppressor gene ECRG4 in lung |
|
| Real-time analysis of the kinetics of angiogenesis and vascular permeability in an animal model of wound healing |
|
| Receptor-mediated gene transfer by phage-display vectors: applications in functional genomics and gene therapy. |
|
| Receptor-targeted gene delivery using multivalent phagemid particles |
|
| Reducing the heterogeneity of chemically conjugated targeted toxins: homogeneous basic FGF-saporin |
|
| Relative potencies of human, rat, bovine/caprine, porcine and ovine hypothalamic growth hormone-releasing factors to release growth hormone by the rat anterior pituitary in vitro |
|
| The Response to Burn Injury in Mice With Human Hematolymphoid Systems |
|
| Role of p38 MAPK in burn-induced intestinal barrier breakdown |
|
| Role of pro-opiomelanocortin-derived peptides in the regulation of steroid production by human fetal adrenal cells in culture |
|
| Selection of internalizing ligand-display phage using rolling circle amplification for phage recovery |
|
| Somatostatin-28 [1-12]-like peptides. |
|
| Stimulating the central nervous system to prevent intestinal dysfunction after traumatic brain injury |
|
| Sustained effects of gene-activated matrices after CNS injury |
|
| Synthesis and in vitro bioactivity of human growth hormone-releasing factor analogs substituted at position-1. |
|
| Targeted transfection of neuronal cells using a poly(D-lysine)-cholera-toxin b chain conjugate |
|
| Targeting Bacteriophage to Mammalian Cell Surface Receptors for Gene Delivery |
|
| Targeting choroid plexus epithelia and ventricular ependyma for drug delivery to the central nervous system |
|
| Targeting the choroid plexus-CSF-brain nexus using peptides identified by phage display |
|
| Targeting the gut barrier: identification of a homing peptide sequence for delivery into the injured intestinal epithelial cell |
|
| Targeting tumor cellsvia EGF receptors: Selective toxicity of an HBEGF-toxin fusion protein |
|
| Thrombin-processed Ecrg4 recruits myeloid cells and induces antitumorigenic inflammation |
|
| Toll-like receptor-4 mediates intestinal barrier breakdown after thermal injury |
|
| Transforming growth factor-beta: role in mediating serum-induced endothelin production by vascular endothelial cells. |
|
| Translocation of FGF2 to the cell surface without release into conditioned media |
|
| Zone 414 |
|
